Prism Medico and Pharmacy Ltd — Others, 07-04-2025: Dear Sir/Madam, Please find the attached statement of investor complaints as per Regulation 13(3) of SEBI (LODR) Regulations, 2015 for the quarter ended 31st March, 2025.

Prism Medico and Pharmacy Limited has announced a board meeting to review the investor complaints report for the quarter ending March 31, 2025. The report indicates a total of zero complaints pending at the beginning of the quarter, none received, none disposed of, and zero unresolved complaints at quarter-end. This clean slate demonstrates effective investor communication and strong management of shareholder relations.

Investor sentiment may lean positively, as no unresolved complaints could signal robust operational transparency and health. However, monitoring will be essential to maintain this favorable outlook.